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When membrane fractions from mouse liver, Ehrlich ascites tumor and MH 134 hepatoma were incubated 
with [y-32P]ATP at 0°C in the presence of MnCl,, ZnCl, and NaVO,, proteins were phosphorylated on 
tyrosines to a larger extent in liver membranes than in tumor membranes. Separation of labelled proteins 
by SDS-gel electrophoresis howed phosphorylated alkali-resistant bands of 170, 140, 130, 80, 56, 53 and 
46 kDa proteins in Ehrlich ascites tumor membranes; liver membranes exhibited more strongly phosphory- 
lated bands of 170,56,53 and 46 kDa proteins. Epidermal growth factor stimulated the tyrosine phosphory- 
lation of only a 170 kDa protein, which was more significant in liver membranes. Liver membranes exhibited 
slightly higher levels of tyrosine protein kinase activity compared to tumor membranes. 
Membrane protein Phosphorylation Phosphotyrosine EGF receptor Cancer 
1. INTRODUCTION 
The tyrosine phosphorylation in proteins is 
known to be catalyzed by specific tyrosine protein 
kinases which have been found to reside in on- 
cogene products [l] and membrane receptors of 
various growth factors [2-51. Although the exact 
physiological significance of the tyrosine 
phosphorylation is not known, the reaction has 
been suggested to correlate with cell transforma- 
tion and proliferation [6,7]. To find a clue as to the 
roles of the reaction in the control of cell transfor- 
mation, phosphorylation of tyrosine in en- 
dogenous proteins and exogenous tyrosine- 
glutamate copolymers by membrane fractions 
from mouse liver and ascites tumor cells was 
compared. 
Abbreviations: EGF, epidermal growth factor; PMSF, 
phenylmethylsulfonyl fluoride; SDS-PAGE, SDS- 
polyacrylamide gel electrophoresis 
2. EXPERIMENTAL 
Membrane fractions (P2 fractions) were 
prepared from male ddy and C3H mouse livers as 
in [8] except that all buffer solutions contained 
1 mM EDTA and 0.5 mM PMSF. Ehrlich ascites 
tumor and MH134 hepatoma cells were inoculated 
intraperitoneally to ddy and C3H mice, respective- 
ly. The tumor cells were washed 3-4 times with 
0.137 M NaCl, 2.7 mM KCI, 1.47 mM KH2P04, 
0.84 mM NazHP04,0.5 mM PMSF, 1 mM EDTA 
(pH 7.4), and cells were homogenized with 5 vols 
of 0.02 M boric acid, 0.5 mM PMSF and 1 mM 
EDTA (pH 10.2) in a Dounce homogenizer (loose- 
fitting, 60 strokes). Membrane fractions were 
prepared from the homogenate as in [9]. The mem- 
brane fractions were suspended in 20 mM Hepes, 
1 mM EDTA and 0.5 mM PMSF (pH 7.4) 
(7-12 mg protein/ml) and stored at - 80°C and 
used within a week. Judging from the increase in 
the specific activity of 5 ’ -nucleotidase, plasma 
membranes were purified lo-fold from the 
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homogenates. Electron microscopic examination 
of the membrane fractions and measurements of 
marker enzymes indicated that the fractions con- 
tained primarily vesicular elements derived from 
the plasma membrane and smooth endoplasmic 
reticulum and little nonmembranous material. 
For phosphoamino acid analysis, membrane 
phosphorylation with [y-32P]ATP (8-20 x 
lo3 cpm/pmol) was carried out in 0.42 ml of the 
mixture as in fig. 1 and stopped by making the mix- 
ture 25% in trichloroacetic acid. The insoluble 
material was collected by centrifugation, washed 
with ethanol-ether (1: 1) and chloroform-methanol 
(2: l), and dried. The phosphorylated 170-kDa 
protein was extracted from the gel after SDS- 
PAGE as in [lo] except that 2-mercaptoethanol 
treatment was omitted. The dried samples were 
suspended in 0.3 ml of 0.05 M NH4HCO3 and 
170K- 
5% 
4GK- 
digested with trypsin (l/10 (w/w) of protein) for 
2 h at 30°C. Acid hydrolysis in the presence of 
4 mM phenol and analysis of hydrolysates by elec- 
trophoresis on Whatman 3MM paper at pH 3 5 for 
70 min at 3 kV followed by ascending paper 
chromatography were performed as in [l I]. Each 
ninhydrin spot of phosphoamino acid standards 
was excised, destained as in [12] and the 32P count 
measured by Cerenkov radiation. The breakdown 
of phosphoserine (24.7%), phosphothreonine 
(6.3%) and phosphotyrosine (52.3%) during the 
hydrolysis, was taken into account in the deter- 
mination of the relative percent of these 
phosphoamino acids. 
Tyrosine protein kinase was assayed in 60 ,ul 
mixture containing 20 mM Hepes (pH 7.4), 3 mM 
MnC12, 1OpM ZnClz, 30,~M NaVO3, 0.5 mM 
dithiothreitol, 0.2% Nonidet P-40, 0.1 mg/ml 
I, -170K 
-14OK 
-130K 
-4SK 
Fig.1. Phosphorylation of membrane proteins from ddy mouse liver (a-d) and Ehrlich ascites tumor (e-h). 
Phosphorylation was carried out at 0°C for 10 min in a 60 ,uI mixture containing: 20 mM Hepes (pH 7.4), 1 mM MnCl2, 
10 PM ZnCh, 30 pM NaVOs, 50,4g membrane protein and 15 PM [T-~~P]ATP (3 x lo3 cpm/pmol) in the absence (a, 
c, e, g) or presence (b, d, f, h) of 0.22 PM EGF. Before adding [Y-~~P]ATP, the rest of the mixture (40 ~1) was incubated 
at 0°C for 10 min. The reaction was stopped and applied to SDS-PAGE as in [16]. The gels were stained with Coomassie 
blue, dried and autoradiographed before (a, b, e, f) and after (c, d, g, h) alkali treatment [17]. Exposure times were 
3 days (a, b, e, f), 7 days (c, d) and 21 days (g, h) with an intensifying screen at -80°C. 
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tyrosine-glutamate (1 : 4) copolymers (Z% 28 000, 
Sigma) [ 131, 15 PM [y-32P]ATP (800 cpm/pmol), 
and 1.4 /rg protein of membrane fractions. After 
10 min at 3O”C, a 50 ~1 aliquot was spotted on 
Whatman 3MM paper, and further processed as in 
[14]. The control value without substrate was sub- 
tracted from the complete value. 
3. RESULTS AND DISCUSSION 
When membrane fractions were incubated with 
[y-32P]ATP at 0°C for 10 min in the presence of 
MnC12, ZnCl2 and NaVO3, 15-25 pmol of Pi was 
incorporated per mg of membrane protein with 
mouse liver and 8-16 pmol with tumor cells (table 
1). Phosphoamino acid analysis revealed that 
66-789’0 of the Pi incorporated into mouse liver 
membrane proteins and 28-38% of Pi incor- 
porated into tumor membrane proteins were 
recovered as phosphotyrosine. Ten times more Pi 
was incorporated into tyrosines in ddy mouse liver 
membrane proteins than in Ehrlich as&es tumor 
membrane proteins. Little difference in the 
amount of Pi incorporated into serine and 
threonine was observed in these same fractions. 
Also, more tyrosine phosphorylation was observed 
in C3H liver membranes than in MH 134 hepatoma 
membranes. It is not due to procedural differences 
in preparation of the membranes, since ddy mouse 
membranes prepared by the same procedure as for 
Ehrlich ascites tumor membranes also showed 
greater tyrosine phosphorylation (not shown). It is 
also not due to the differences in the 
dephosphorylation of phosphoproteins. 32Pi 
release from the phosphorylated proteins was 
measured by adding 100 PM cold ATP after 
phosphorylation of the membrane proteins with 
5 PM [y-32P]ATP at 0°C for 5 min. Not more than 
7% of the incorporated 32P was released at 0°C for 
5 min from membrane proteins of either ddy 
mouse liver or Ehrlich ascites tumor. The lower 
tyrosine phosphorylation in the tumor membranes 
is probably not due to the high content of en- 
dogenous phosphotyrosines. Since alkaline 
Table 1 
Phosphorylation and phosphoamino acid analysis of membrane proteins 
Membrane Addition Pi incorporated 
into protein 
(pmol/mg protein) 
Pi incorporated (pmol/mg protein) into 
P-Serine P-Threonine P-Tyrosine 
- 
Liver (ddy) 
Liver (ddy) 
Liver (C3H) 
Liver (C3H) 
Tumor (Ehrlich) 
Tumor (Ehrlich) 
Tumor (MHI 34) 
Tumor (MH 134) 
None 
EGF 
None 
EGF 
None 
EGF 
None 
EGF 
24.6 f 0.1 
35.0 + 6.9 
14.5 * 0.9 
24.1 + 1.9 
8.07 f 0.50 
9.43 * 1.16 
16.4 * 4.4 
19.1 + 4.1 
3.73 + 0.61 
(15) 
3.93 * 0.72 
(11) 
4.21 + 1.70 
(28) 
3.29 + 1.16 
(13) 
4.04 f 0.25 
(50) 
3.61 Z!I 0.28 
(39) 
8.03 f 1.91 
(49) 
8.98 + 2.18 
(47) 
1.60 + 0.06 19.25 f 0.75 
( 7) (78) 
1.11 + 0.15 30.00 + 6.40 
( 4) (85) 
0.80 + 0.06 9.50 * 0.80 
( 6) (66) 
0.68 f 0.09 20.78 & 0.82 
( 3) (84) 
1.79 + 0.15 
(22) 
2.12 + 0.56 
(22) 
2.24 f 0.98 
(13) 
2.69 f 0.63 
(14) 
2.24 + 0.09 
(28) 
3.70 + 0.33 
(39) 
6.14 + 1.49 
(38) 
7.44 + 1.29 
(39) 
Phosphorylation and SDS-PAGE of membrane proteins were carried out as in fig. 1. After staining, all protein bands 
in a gel were excised and the “P count was measured. Phosphoamino acid analysis was performed as described in section 
2. The values in parentheses indicate relative percent of phosphorylated serine, threonine and tyrosine in the sample. 
The average with the range of values for two separate experiments is given 
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phosphatase ffectively removes Pi from tyrosine 
hydroxyl of proteins at neutral pH [15], these 
membrane fractions (5Opg proteins) were in- 
cubated with alkaline phosphatase (0.25 pg, Sigma 
type VII-S) at 30°C for 10 min in 60~1 of 20 mM 
Hepes (pH 8.0) (this treatment removed 50-60% 
32P, from prelabelled membrane fractions). After 
removing the phosphatase by centrifugation 
followed by washing, the treated membranes were 
phosphorylated with [y-32P]ATP under the condi- 
tions as described in fig.1 in the absence of EGF. 
The alkaline phosphatase treatment increased the 
phosphorylation of membrane proteins by only 
5-10% with either liver or Ehrlich ascites tumor 
membranes. Since the Pi incorporation reached a 
plateau and at least 30% of the added [T-~~P]ATP 
remained unhydrolyzed under these conditions, 
these differences in tyrosine phosphorylation may 
reflect the availability of tyrosines in these mem- 
brane preparations. 
The phosphorylated membrane proteins were 
next applied to SDS-PAGE (8% acrylamide) to 
determine whether or not liver and ascites tumor 
cells have distinct tyrosine phosphoproteins. Since 
the phosphotyrosyl bond is more stable to alkali 
treatment than the phosphoseryl or phospho- 
threonyl bonds [17], gels were treated with 1 M 
KOH for 2 h at 55°C and the remaining radioac- 
tive protein bands were detected as tyrosine phos- 
phoproteins by autoradiography (fig.1). In ddy 
mouse liver membranes, protein bands of 170, 56, 
53 and 46 kDa seemed to be phosphorylated at 
tyrosine. Molecular masses of proteins which con- 
tained alkali-stable phosphate and migrated near 
the dye front, were determined to be 20, 11 and 
10 kDa by SDS-PAGE (15% acrylamide) (not 
shown). In addition to these bands, other alkali- 
stable bands of 140, 130 and 80 kDa were detected 
in Ehrlich ascites tumor membranes. 32P counts in 
these alkali-stable bands were about 10 times 
higher in liver membranes than in tumor 
membranes. 
Incubation of these membranes with EGF in- 
creased the Pi incorporation by 42-7 1% with liver 
membranes and by 17% with tumor membranes. 
Phosphoamino acid analysis indicated that only 
the phosphorylation of tyrosine was significantly 
increased by EGF (table 1). 
The EGF pretreatment caused an increase in the 
phosphorylation of a 170-kDa protein (~170) 
without significant increases in the phosphoryla- 
tion of other proteins (fig.1). Densitometric 
analysis of the autoradiograms of KOH untreated 
gels showed that EGF stimulated ~170 
phosphorylation of liver membranes 4-7-fold and 
of tumor membranes 3-fold. Mouse liver ~170 has 
been known to be an EGF receptor which is 
autophosphorylated at tyrosines [18], so that 
Ehrlich tumor p 170 was extracted from a KOH un- 
treated gel and the phosphoamino acids were 
analyzed. Relative percents of 32Pi ncorporated in- 
to serine, threonine and tyrosine were 29, 5 and 
66%, respectively. These results suggest hat the 
~170 in the tumor membranes is also an EGF 
receptor. 
Tyrosine protein kinase activities (pmol/min per 
mg protein, mean + SD) towards tyrosine- 
glutamate (1: 4) copolymers were 229 f 94 (ddy 
liver), 285 + 40 (C3H liver), 185 & 16 (Ehrlich 
ascites tumor) and 162 f 57 (MH134 tumor). The 
enzyme activity was not affected by 0.22 PM EGF. 
The slightly higher activity in liver membranes 
than in tumor membranes may reflect in part on 
the differences in the amount of tyrosine 
phosphorylation of these membrane proteins. 
The lower levels of tyrosine phosphorylation in 
tumor membranes than liver membranes upport 
the notion that increased phosphorylation of 
tyrosine, which has been observed in transformed 
cells after Rous sarcoma virus infection [ 111, is 
neither a universal mechanism of transformation 
nor an inevitable secondary cellular response to 
transformation [ 191. Tyrosine protein kinase ac- 
tivity towards a synthetic tyrosine-containing pep- 
tide, has been found to be markedly lower in the 
leukemic cell lines and in proliferating normal 
bone marrow cells than in normal lymphocytes 
[20]. High percentages of phosphorylated tyrosine 
were also found in the particulate fractions from 
non-proliferating anuclear cells, platelets and red 
blood cells [21]. 
These results implicate that a high phosphoty- 
rosine content in membranes, at least after in vitro 
phosphorylation, is not necessarily associated with 
cancer. 
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